Glenmark Pharmaceuticals Limited's most recent trade in Alivus Life Sciences Ltd. was a Disposal of 9,609,571 Equity Shares done at an average price of Rs. 830.7 . Disclosure was reported to the exchange on July 15, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Glenmark Pharmaceuticals Limited in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alivus Life Sciences | Glenmark Pharmaceuticals Limited | Promoter | Disposal | 15 Jul 2024 | 9,609,571 | 0 (0%) | 7.84% | 830.7 | 7,983,000,234 | 11 Jul 2024 12 Jul 2024 |
Insider Trading | Equity Shares | Others |
| Alivus Life Sciences | Glenmark Pharmaceuticals Limited | Promoter | Disposal | 13 Mar 2024 | 24,505,435 | 9,609,571 (7.84%) | 20.00% | 598.0 | 14,654,095,299 | 12 Mar 2024 12 Mar 2024 |
Insider Trading | Equity Shares | Off Market |
| Alivus Life Sciences | Glenmark Pharmaceuticals Limited | Promoter | Disposal | 07 Mar 2024 | 67,389,944 | 34,115,006 (27.84%) | 55.00% | 598.0 | 40,298,765,727 | 06 Mar 2024 06 Mar 2024 |
Insider Trading | Equity Shares | Off Market |
| Alivus Life Sciences | Glenmark Pharmaceuticals Limited | Promoter | Pledge | 25 Sep 2023 | 9,609,571 | 101,504,950 (82.84%) | 7.84% | 615 | 5,909,886,165 | 21 Sep 2023 21 Sep 2023 |
Insider Trading | Equity Shares | Others |